Not enough evidence to justify ovarian cancer screeningBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7185.687 (Published 13 March 1999) Cite this as: BMJ 1999;318:687
- Richard Woodman
Screening women for ovarian cancer should not be considered until the potential benefit, harm, and cost have been assessed in randomised clinical trials, says a report from the NHS Centre for Reviews and Dissemination.
Dr Ruth Bell, a visiting research fellow at the centre, and her coauthors said that a systematic review of prospective screening studies showed that ultrasound screening and the serum test for CA125 could detect ovarian cancer …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial